oxidopamine hydrochloride has been researched along with tanshinone ii a in 1 studies
| Studies (oxidopamine hydrochloride) | Trials (oxidopamine hydrochloride) | Recent Studies (post-2010) (oxidopamine hydrochloride) | Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) |
|---|---|---|---|---|---|
| 18 | 0 | 13 | 61 | 0 | 41 |
| Protein | Taxonomy | oxidopamine hydrochloride (IC50) | tanshinone ii a (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 4.82 | |
| Spike glycoprotein | Betacoronavirus England 1 | 0.8 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.8 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 11.2 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 11.2 | |
| Telomerase reverse transcriptase | Homo sapiens (human) | 2.75 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.8 | |
| Procathepsin L | Homo sapiens (human) | 0.8 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.14 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.2 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.1855 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.69 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 2.14 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.59 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 6.855 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 6.855 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for oxidopamine hydrochloride and tanshinone ii a
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |